Recent Advances in Hematology - 5

1. Molecular Diagnosis of Inherited Hemolytic Anemias Beyond Thalassemia
2. Recent Advances in the Prognostication of Chronic Lymphocytic Leukemia and Multiple Myeloma
3. WHO 2022 Update of the Classification of MDS and MPN: Practical Algorithms for Diagnosis
4. Critical Appraisal of WHO and ICC Classification of Acute Myeloid Leukemia
5. CAR-T Therapy: Managing Toxicity and Long-term Outcome Assessment
6. Noninvasive Prenatal Diagnosis for Sickle Cell Anemia and Thalassemia
7. Molecular Landscape of Diffuse Large B-cell Lymphoma
8. B-ALL Management in the Era of Immunotherapy
9. Diagnosis of Ph-like B-ALL: The Ideal Approach in the Indian Setting
10. Point-of-Care Testing in Coagulation
11. MicroRNAs in Hematology
12. How to Assess Measurable Residual Disease in Acute Myeloid Leukemia
13. Relevance of Screening of Myeloid/Lymphoid Neoplasms for Germline Predisposition
14. Recent Advances in the Diagnosis and Treatment of Hodgkin Lymphoma
15. Updates in the Diagnosis of the Antiphospholipid Syndrome
16. Heparin-induced Thrombocytopenia and Vaccine-induced Thrombocytopenia
17. Direct Oral Anticoagulants: When to Prescribe and How to Monitor?
18. How to Approach a Case of Microcytic Hypochromic Anemia Not Responding to Iron Therapy
19. Measurable Residual Disease in B-cell Acute Lymphoblastic Leukemia: What is Known and What is New?
20. Revisiting B-ALL MRD in CAR-T Cell and Blinatumomab Era
21. Measurable Residual Disease in T-cell Acute Lymphoblastic Leukemia/Lymphoma
22. Setting Up a Diagnostic Laboratory: Costing and Inventory Management
23. How to Set Up a Molecular Hematology Laboratory?
24. Optical Genome Mapping: Introduction of New Era of Cytogenomics in Hematological Malignancies
25. Hemoglobin Fraction Analysis in the Diagnosis of Hemoglobinopathies - Methods, Advantages, Pitfalls and Updates
26. Approach to Monocytosis
27. Juvenile Myelomonocytic Leukemia - Recent Updates
28. Case-based Approach to Eosinophilia
29. Monitoring and Follow-up of Chronic Myeloid Leukemia Including Tyrosine Kinase Domain Mutation Assessment
30. Primary Immunodeficiency Disorders: Approach to Diagnosis and Treatment
31. New Updates in Histiocytic Disorders: Where do We Stand in 2024?
32. Role of Genomic Techniques in the Management of Acute Leukemia
33. Thrombophilia Workup: When, Whom, and What to Test?
34. Amyloidosis: Newer Insights in Diagnosis
35. Minimal/Measurable Residual Disease in Myeloma
36. Quality Control in Hematology Cell Counters and Coagulation Laboratory: Good Laboratory Practices
37. Immunohematology in Solving Cases of Autoimmune Hemolytic Anemia
38. Recent Advances in Splenic Lymphomas: Histopathology and Flow Cytometry
39. Genetics in Hemophilia and Platelet Function Disorders
40. Neonatal Transfusion - Newer Parameters in Cell Counters

Vandana Puri MD (Pathology) DNB (Pathology) DM (Hematopathology) MNAMS
Jasmita Dass MD (Pathology) DM (Hematopathology)
Brig Tathagata Chatterjee MD (Pathology) PGD (Oncopathology) DM (Hematopathology) FIAMS FUICC